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Summary. The role of cell-mediated cytotoxicity in the 
pathogenesis of ulcerative colitis and Crohn's disease 
has been controversial since reports indicating either a 
decreased, or an increased, activity of cytotoxic T cells 
in active stages of inflammatory bowel disease exist. 
Some of these discrepancies may be attributed to the fact 
that so far mostly peripheral blood lymphocytes rather 
than intestinal T cells have been examined. To overcome 
some of these limitations we performed in situ 
hybridizations for  the detection of perforin and 
granzyme A mRNA expressing cells, i.e. of cytotoxic 
cells activated in situ, in the affected intestinal mucosa. 
These studies revealed increased frequencies of 
activated, cytotoxic T cells in active stages of ulcerative 
colitis and Crohn's disease. Interestingly, activated 
perforin mRNA expressing T cells are present both in 
the CD4 and in the CD8 T cell subsets. In the latter T 
cell subset up to 60% of the mucosal T cells isolated 
from the affected sites express perforin mRNA at 
detectable levels. The elevated frequency of activated 
cytotoxic cells and their histological distribution also in 
close proximity to the epithelial cells may thus indicate 
an important role for cytotoxic cells in the pathogenesis 
of inflammatory bowel disease since activated cytotoxic 
T cells may further exacerbate the inflammatory process 
through the production of pro-inflammatory cytokines 
such as interferon-y or tumor necrosis factor-a, but also 
through the release of pro-inflammatory cytokines and 
chemokines upon lysis of epithelial cells and the 
increased influx of lumina1 antigens at the site of 
epithelia1 erosions. 
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Introduction 
Crohn's disease (CD) and ulcerative colitis (UC) 
represent the two major clinical entities of chronic 
relapsing inflammatory bowel disease (IBD). Despite 
increasing research activities etiologic agents or well- 
defined factors responsible for the initiation of the 
inflammatory response still remain enigmatic. In the 
past, several factors including familial disposition, 
psychosocial factors, dietary factors and bacterial or 
viral infections have been postulated to contribute to the 
initiation andlor perpetuation of the disease (Fig. 1). Our 
improved understanding of immunoregulatory 
mechanisms and the increased interest of the research 
community in mucosal immunity lead to a large number 
of studies focusing on the role of aberrant immune 
reactions in the pathogenesis of IBD. Consequently, in 
the past few years evidence for a crucial involvement of 
a dysregulated immune response in the intestinal mucosa 
in patients with IBD has accumulated. 
Indications for immunopathological factors 
contributing to the pathogenesis of IBD 
The occurrence of autoantibodies against perinuclear 
cytoplasmic antigens in neutrophils (pANCA) has been 
long considered as a main indication for the contribution 
of the immune system to the pathogenesis of UC. 
Although more recent studies demonstrated that pANCA 
represents the consequence of a mucosal immune 
response rather than the disease initiating event (Targan 
et al., 1995) in UC, indications for an involvement of the 
immune system in the pathogenesis of UC and CD have 
increased considerably over the past few years. Most 
compelling evidence for a contribution of a dysregulated 
immune response to the initiation and perpetuation of 
IBD has been obtained in several mouse models of 
colitis. Mice lacking specifically the gene encoding 
interleukin (1L)-2 due to homologous recombination of 
the endogenous gene locus with a disrupted, non- 
functional gene, spontaneously develop a colitis-like 
disease at an advanced stage of age when kept under 
conventional conditions of maintenance (Sadlack et al., 
1993). The spontaneous development of a colitis in IL-2- 

















